The Arabidopsis embryonic root meristem is initiated by the specification of a single cell, the hypophysis. This event critically requires the antagonistic auxin response regulators MONOPTEROS and BODENLOS, but their mechanism of action is unknown. We show that these proteins interact and transiently act in a small subdomain of the proembryo adjacent to the future hypophysis. Here they promote transport of auxin, which then elicits a second response in the hypophysis itself. Our results suggest that hypophysis specification is not the direct result of a primary auxin response but rather depends on cell-to-cell signaling triggered by auxin in adjacent cells.
Introduction
The Arabidopsis zygote divides asymmetrically to produce two daughter cells with different fates, an apical embryonic cell and a basal extraembryonic cell. At the boundary between the lineages derived from these cells, the root meristem founder cell-the hypophysis-is established from the extraembryonic (suspensor) cell directly adjacent to the embryonic cell lineage (proembryo). Hypophysis specification occurs when the proembryo consists of about 30 cells and when a maximum of auxin response can be visualized in the future hypophysis (Friml et al., 2003) . Hypophysis specification requires members of two protein families involved in auxin response, the auxin response transcription factor MONOPTEROS (MP/ARF5) (Berleth and Jü rgens, 1993; Hardtke and Berleth, 1998) and the auxin response inhibitor BODENLOS (BDL/IAA12) (Hamann et al., 1999 (Hamann et al., , 2002 . MP and BDL transcripts accumulate in the proembryo rather than in the adjacent cell whose fate is to be specified (Hamann et al., 2002) . However, because plant transcription factors can move from the cell of synthesis into the adjacent cell of action (Lucas et al., 1995; Sessions et al., 2000; Nakajima et al., 2001) , it is unclear where and how MP and BDL proteins act in hypophysis specification.
Results and Discussion
BDL Acts through Interaction with MP Similarity of the mutant phenotypes resulting from loss of MP protein or stabilization of BDL protein suggests that MP and BDL act in the same developmental process (Berleth and Jü rgens, 1993; Hamann et al., 1999) , and yeast studies suggest that they may interact (Hamann et al., 2002; Hardtke et al., 2004; Weijers et al., 2005) . To determine whether BDL and MP interact in planta, we expressed 63HA epitope-tagged MP (MP:63HA) and 33GFP-tagged BDL (33GFP:BDL or 33GFP:bdl) from genomic fragments. MP:63HA rescued mp mutant embryos (see Experimental Procedures) and 33GFP:bdl mimicked the bdl mutant phenotype (see Figure S1 in the Supplemental Data available with this article online), indicating that both are functional, as was previously shown for bdl:GUS . MP:63HA was recovered from plant extracts by recombinant BDL in pull-down experiments ( Figure 1A ). Reciprocal coimmunoprecipitation experiments with transgenic plants expressing both MP:63HA and 33GFP:BDL demonstrated the in planta interaction between BDL and MP ( Figure 1B) . A deletion series of BDL in yeast two-hybrid assays showed that domains III/IV of BDL are required for interaction with the C terminus of MP ( Figure 1C ). Full-length stabilized mutant bdl protein induced a rootless phenotype ( Figure 1D ; 10% of 221 T1 seedlings were rootless), whereas a version lacking domains III/IV was no longer able to do so ( Figure 1E ; none of more than 50 T1 seedlings were rootless). Furthermore, expression of MP from the strong embryonic RPS5A promoter (Weijers et al., 2001 ) rescued the rootless phenotype of bdl ( Figure 1F ; of 15 seedlings preselected for curled up cotyledons indicative of the bdl mutation, 8 were bdl homozygotes). This result is consistent with the observation that MP overexpression rescues the postembryonic phenotypes of the bdl mutant (Hardtke et al., 2004) . Consistent with their physical and genetic interaction, MP:63HA (Figures 1G and 1J) and 33GFP:BDL ( Figures 1H and 1K ) proteins colocalize in nuclei of the seedling root (Figures 1I and 1L) . Taken together, these data indicate that BDL and MP interact in planta and that BDL acts by inhibiting MP.
MP and BDL Act on Hypophysis Specification in a Small Domain of Adjacent Cells
Both bdl and mp mutants fail to specify the hypophysis (Berleth and Jü rgens, 1993; Hamann et al., 1999) , although neither BDL nor MP mRNA accumulates in the hypophysis prior to its division (Hamann et al., 2002) . This suggests that BDL and MP genes might act noncell-autonomously in hypophysis specification. Several plant transcription factors act non-cell-autonomously by moving into adjacent cells (Lucas et al., 1995; Sessions et al., 2000; Nakajima et al., 2001) . To address whether movement of BDL or MP protein mediates their non-cell-autonomous action, MP:63HA, BDL:GUS, and bdl:GUS proteins were localized in the embryo (Figure 2 ). All proteins localize first in the preglobular proembryo *Correspondence: gerd.juergens@zmbp.uni-tuebingen.de (Figures 2A, 2D, and 2G) , and then only in the inner cells of the proembryo (Figures 2B, 2C, 2E, 2F, 2H, and 2I) . This contraction of expression follows the dynamic change of mRNA distribution (Hamann et al., 2002) . Although bdl:GUS protein is present at higher levels than BDL:GUS, their expression patterns are identical (Figures 2A-2F ). Importantly, neither MP nor BDL protein accumulates in the hypophysis (Figures 2B, 2E, and 2H) . This lack of movement demonstrates that MP and BDL act non-cell-autonomously in hypophysis specification through a secondary signal.
The expression pattern of MP and BDL is dynamic, and phenotypes of mp and bdl mutants are not restricted to defective root formation (Berleth and Jü rgens, 1993; Hamann et al., 1999; Friml et al., 2003) . To define which of the MP/BDL-expressing cells are involved in hypophysis specification, we expressed HA-tagged MP or stabilized bdl in different subsets of embryo cells using the GAL4-UAS two-component expression system (Haseloff, 1999) (Figures 3A-3D ). The driver Q0990 expresses GAL4 and its reporter ER-localized GFP in provascular cells of the central region immediately adjacent to the hypophysis ( Figure 3A ). MP expression from this driver restored root development in 94% of mp mutant seedlings (1.4% mp seedlings; N = 421, compared to 25% mp seedlings observed in mp heterozygous lines; Figure 3B ). Likewise, expression of stabilized bdl in this domain caused a perfect phenocopy of the hypophysis and root defects observed in bdl or mp mutants (Figure 3D ; Berleth and Jü rgens, 1993; Hamann et al., 1999) . In contrast, MP expression in the protoderm using the LTP1 promoter (Thoma et al., 1994) did not rescue the basal defect of mp mutants (0% rescue; 30% mp seedlings; N = 327; Figure 3C ) and no effects on root development were observed when bdl was expressed in the apical region of the globular embryo (not shown). These results demonstrate that the downstream signal is generated in the central cells of the proembryo that are immediately adjacent to the hypophysis.
MP and BDL Act Transiently in Embryonic
Root Initiation BDL and MP are not only expressed in the proembryo but also in the apical daughter cell of the hypophysis (Hamann et al., 2002) , raising the possibility that they also act later in root meristem development. Such later effects would be masked in bdl and mp embryos because the earliest BDL/MP-dependent response is abolished. We therefore expressed 33GFP:bdl in the hypophysis and its apical daughter using the SCARECROW promoter (pSCR; Wysocka-Diller et al., 2000) , which is also active in the ground tissue. Stabilized 33GFP:bdl ( Figure 3F ), but not wild-type 33GFP:BDL ( Figure 3E ), protein accumulated in the hypophysis and ground tissue. Although the stabilized protein ( Figure 3H ) interfered with gravitropic growth of inflorescence branches in later development ( Figure 3J ; compare to Figure 3I ), it did not inflict embryonic root defects ( Figure 3G ). Thus, BDL-dependent MP activity is not required in the hypophysis derivatives for embryonic root development but rather limited to proembryo cells. To determine when the fate of the hypophysis is firmly established, we generated an inducible version of stabilized bdl. A fusion between bdl and the steroid binding domain of the rat glucocorticoid receptor (GR:bdl) (Sablowski and Meyerowitz, 1998) was expressed from the RPS5A promoter. Treatment of cells with dexamethasone (Dex) induced nuclear import of the otherwise cytoplasmic GR:bdl protein, and caused a reversible postembryonic phenotype similar to that found in bdl heterozygotes (not shown). Developing seeds of various stages from GR:bdl plants were cultured on control medium, or on medium supplemented with Dex. When seeds contained preglobular embryos with an undivided hypophysis ( Figure 3K ) at the start of the culturing, Dex induced the full range of bdl and mp phenotypes, including failure to initiate a root and cotyledon defects (Figures 3M and 3O) . Strikingly, Dex treatment did not induce rootless phenotypes in embryos after the hypophysis had divided ( Figures 3L, 3N , and 3O). In such embryos, Dex still induced apical defects ( Figure 3N ). Hence, even though MP and BDL are active in the proembryo from the division of the zygote, MP/BDL-mediated auxin response in root initiation need not occur until immediately prior to hypophysis division. Taken together, our data suggest that the uppermost extraembryonic cell is specified as hypophysis in response to a transient MP/BDLdependent signal generated in the immediately adjacent provascular cells of the proembryo.
MP/BDL Signaling in the Proembryo Promotes Auxin
Transport to the Future Hypophysis Auxin accumulates in the hypophysis at the time of its specification (Friml et al., 2003) . This accumulation requires polar localization of the PIN1 auxin efflux protein in the proembryo ( Figure 4A ), which makes auxin a candidate for the MP/BDL-dependent signal. PIN1 is expressed in the embryo in the same cells as MP and BDL (Steinmann et al., 1999) . Another member of the PIN family, PIN4, is also expressed in the proembryo at globular stages and functionally redundant with PIN1 at the seedling stage (Vieten et al., 2005) . However, its expression in the proembryo commences only after hypophysis division ( Figure S2 ) and we thus focused our analysis on PIN1. Expression of PIN1 in the central region of the proembryo and of the auxin-dependent DR5::GFP reporter in the hypophysis are lacking in bdl mutant embryos ( Figure 4B ). To address whether auxin could be the MP/BDL-dependent signal generated in the proembryo cells immediately adjacent to the hypophysis, PIN1 protein localization and DR5 promoter activity were analyzed in embryos that expressed bdl from the Q0990 GAL4 driver (Figures 4C-4F ). We constructed a nuclearlocalized DR5::SV40:33GFP (DR5::nGFP) reporter to distinguish DR5 promoter activity from the intrinsic ERlocalized GFP expression driven by GAL4 in the Q0990 line (Q0990>>erGFP). In these embryos, PIN1 signal was completely lost from the bdl-expressing domain, but unaffected in all other PIN1-expressing cells ( Figure 4D ; compare with Figure 4C ). Consistent with reduced auxin transport activity in the proembryo, DR5::nGFP reporter activity was lacking in the hypophysis ( Figure 4F ; compare with Figure 4E ). Interestingly, auxin response was not affected in subtending suspensor cells (Figures 4G and 4H) , suggesting that bdl does not generally interfere with auxin response in the basal cell lineage but only in its uppermost derivative. Therefore, PIN1 expression and auxin translocation to the hypophysis are positively regulated by BDL-dependent MP activity in the adjacent proembryo cells, which identifies auxin as a mobile signal downstream of MP and BDL. To address whether accumulation of auxin in the hypophysis is sufficient for its specification, developing mp or bdl seeds were cultured on medium supplemented with the strong auxin analog 2,4-D. If auxin were the sole signal downstream of MP and BDL, 2,4-D should restore hypophysis specification and root initiation in these mutants. As previously reported (Sauer and Friml, 2004) , 2,4-D induced cotyledon fusion in wild-type embryos ( Figures 4I and  4J) . Similarly, 2,4-D treatment induced cotyledon fusion in bdl (Figures 4K and 4L) and mp (not shown) embryos. However, hypophysis specification and root initiation were not rescued by 2,4-D treatment in bdl ( Figure 4L ) or mp (not shown) embryos, indicating that accumulation of auxin in the hypophysis is not sufficient for its specification. These data imply the existence of other MP/BDL-dependent proembryo-derived signals in hypophysis specification.
A Model for Auxin-Dependent Embryonic Root Initiation
Our findings suggest a model of how an initially extraembryonic cell adopts an embryonic fate (hypophysis) in response to auxin accumulation in the adjacent proembryo ( Figure 4M ). Auxin triggers the release of the ARF transcription factor MP from its Aux/IAA inhibitor BDL by complexing the latter with F box auxin receptors, which results in BDL degradation via the ubiquitinproteasome pathway . As a consequence, MP positively regulates expression of PIN1, which by its polar localization mediates basally directed auxin flow within the provascular cells of the proembryo. The resulting basal accumulation of auxin may contribute to hypophysis specification, which would require another ARF x -Aux/IAA y pair from among the 23 ARFs and 29 Aux/IAAs (Remington et al., 2004) . Although auxin is a signal downstream of MP/BDL, its basal accumulation alone appears not to be sufficient to specify the hypophysis. Thus, it is conceivable that other as yet unidentified MP/BDL-dependent signals act in concert with auxin. This interpretation is supported by our finding that other suspensor cells respond to auxin in an MP/BDL-independent manner and do not adopt hypophysis fate. In summary, our study reveals an unexpected mode of action for auxin in pattern formation. Rather than specifying the fate of a cell directly, auxin elicits a primary response in adjacent cells and is then relayed as part of a secondary signal. It will be interesting to determine whether this is a more general mechanism underlying auxin-mediated developmental processes.
Experimental Procedures Plant Material and Growth Conditions
Plants were grown in a 16 hr light-8 hr dark cycle at 18ºC or 23ºC. Typically, seeds were germinated and grown on solid 1/2 MS medium for 10 days and then transplanted to soil for further growth. The bdl mutant (Hamann et al., 1999) , ACT LTP1 (pLTP1::GAL4; Weijers et al., 2003) , DR5rev::GFP (Friml et al., 2003) , and BDL:GUS and bdl:GUS lines have been described previously. The Q0990 GAL4 enhancer trap line was generated by Jim Haseloff (University of Cambridge, UK) and obtained through the Arabidopsis Biological Resource Center (Columbus, OH). mp-T370 plants containing the Q0990 driver were kindly provided by M. Aida (Nara Institute of Science and Technology, Nara, Japan). The mp-B4149 allele in Columbia background was a kind gift from Ben Scheres (Utrecht University, The Netherlands). Sequencing of the MP open reading frame amplified from mp-B4149 homozygotes revealed a G to A mutation at the splice acceptor site of the tenth exon. RT-PCR experiments showed the absence of MP mRNA in this mutant. Culturing of immature seeds was performed as described (Sauer and Friml, 2004) . From each silique used for culture, a few seeds were analyzed prior to culturing to determine the developmental stage of the embryos. From the remaining ovules of each silique, half were transferred to control medium, whereas the other half were transferred to medium containing 50 mM 2,4-D or 25 mM dexamethasone and cultured for 1-3 days. Upon culture, seeds were cleared with chloral hydrate (see below) and the phenotype of surviving embryos (those that had progressed from the start stage) was scored. For GAL4-UAS crossing experiments, GAL4 lines were used as female parents, and F1 seeds were harvested 3-5 days after pollination. Where indicated, appropriate lines were manually crossed and plants of F1-F3 generations were analyzed.
Plasmid Construction and Plant Transformation
For constructing MP:63HA, an 8.5 kb EspI-AvrII genomic fragment spanning the entire MP gene, including 4.1 kb upstream and 0.9 kb downstream sequences, was isolated from BAC F6F9, and cloned in pGreenII 0229 (Basta resistance; Hellens et al., 2000) to result in GIIB MP. Subsequently, a 63HA tag coding sequence (CDS) including in-frame BclI sites was PCR amplified from pYM3 (Knop et al., 1999 ; kindly provided by H. van Attikum) and cloned into the BclI site in GIIB MP to result in GIIB MP:63HA. pBDL::Myc:bdl was constructed by replacing the GUS gene in pVKHBDLGUSpA (hygromycin resistance; Hamann et al., 2002) with an N-terminal Myc-tagged bdl cDNA. Domains III/IV of the Myc:bdl cDNA were replaced by the Xlim1 heterodimerization domain (Ung et al., 2001 ). The Myc:bdl: Xlim1 cDNA was also cloned into pVKHBDLGUSpA.
33GFP-tagged BDL was created by cloning a triple eGFP (kindly provided by S. Takada) at the start codon of BDL in a pGreenII 0229 binary vector containing the entire 4.5 kb BDL or bdl gene with an engineered BamHI site at the start codon. UAS::BDL or UAS::bdl were generated by cloning Myc:BDL or Myc:bdl into pSDM7023 , and transferring the UAS::BDL/bdl::tNOS cassettes into pSDM7006 . UAS::MP:HA was constructed by blunt end cloning of a C-terminally HA epitope-tagged MP cDNA into pSDM7023 , and transferring the UAS::MP:HA::tNOS cassette into pSDM7006 . SCR promoter fusions were generated by first cloning a PCR-amplified 2.5 kb SCR promoter (Wysocka-Diller et al., 2000) into pGreenII 0226 (kanamycin resistance; Hellens et al., 2000) containing a NOS terminator (GIIK tNOS) to yield GIIK pSCR-tNOS. Next, 33GFP CDS was cloned at the translational start of Myc:BDL or Myc:bdl, and 33GFP:BDL/bdl were cloned into GIIK pSCR-tNOS. For the nuclear DR5rev::GFP version, the DR5rev promoter was PCR amplified from the DR5rev::GFP vector (Friml et al., 2003) (kindly provided by J. Friml), and cloned into the GIIK tNOS vector. Subsequently, 33eGFP with N-terminal SV40 nuclear localization signal (kindly provided by S. Takada) was cloned into this vector to result in GIIK DR5rev::SV40:33GFP. The dexamethasone-inducible version of stabilized bdl protein was constructed by first cloning a hormone binding domain of rat glucocorticoid receptor (GR) PCR amplified from pRS020 (Sablowski and Meyerowitz, 1998 ; a kind gift from Michael Lenhard) at the N terminus of Myc:BDL or Myc:bdl. Next, Myc:GR:BDL or Myc:GR:bdl was cloned into a pGreenII 0226 (kanamycin resistance) vector containing the AtRPS5A promoter (Weijers et al., 2001 ) and the NOS terminator (GIIK RPS5A-tNOS). The RPS5A::ER:MP construct was generated by first cloning PCRamplified hormone binding domain from human estrogen receptor (ER; Greene et al., 1986) into the N terminus of an HA-tagged MP cDNA , and then transferring ER:MP:HA into GIIK RPS5A-tNOS. This construct was intended to generate estradiol-inducible MP protein. Analysis of transgenic plants showed that this protein was active without estradiol, and it was therefore used as MP gain of function. All constructs were transformed into A. tumefaciens containing the pSoup plasmid (Hellens et al., 2000) , and Columbia wild-type, mp-B4149, UAS::BDL, or UAS::bdl (for the DR5rev::SV40:33GFP construct) plants were transformed by floral dip (Clough and Bent, 1998) . Primary transformants were selected on 1/2 MS plates containing 20 mg/L hygromycin, 50 mg/L kanamycin, or 15 mg/L phosphinotricin. Rescue of mp-B4149 homozygotes by the MP:63HA transgene was tested by crossing a line with a single transgene copy to the mp-B4149 allele, and scoring for mp segregation in the F2 generation.
Protein Analysis
Protein extracts were prepared and analyzed as described Dharmasiri et al., 2005) using an extraction buffer (EB) containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.5% Triton X-100, 10% glycerol, 1 mM phenylmethyl sulphonyl fluoride, and 13 complete protease inhibitor cocktail (Sigma, Munich, Germany). BDL cDNA was cloned in vector pET16H (Novagen, Schwalbach, Germany), and 103HIS:BDL protein was expressed in Escherichia coli (BL21-DE3) and purified using Ni-NTA agarose (Qiagen, Hilden, Germany) according to standard procedures. For pull-down experiments, 100 ml of Ni-NTA agarose was incubated with equal amounts of cleared protein extract from flower buds of plants expressing MP:63HA, either with or without (approximately) 5 mg 103HIS:BDL protein, incubated on a rotating wheel at 4ºC for 4 hr, and washed three times in EB with 100 mM imidazole. Beads were then boiled in Laemmli buffer and eluates were subjected to Western blotting with peroxidase-coupled anti-HA (1:1,000; Sigma).
For coimmunoprecipitation, extracts were prepared from seedlings expressing both MP:63HA and 33GFP:BDL. Equal amounts of extract were precleared with 50 ml protein A-agarose beads (Roche, Grenzach-Wyhlen, Germany) for 1 hr at 4ºC. Cleared extracts were incubated without antibody, with 5 ml mouse anti-GFP serum (Molecular Probes, Gö ttingen, Germany), or 5 ml mouse anti-HA serum (Babco, Berkeley, CA) for 2 hr at 4ºC. Then, 100 ml protein A-agarose beads were added and protein complexes were precipitated overnight at 4ºC and washed three times in EB. Then, beads were boiled in Laemmli buffer and subjected to Western blotting with mouse anti-GFP (1:1,000; Molecular Probes) and alkaline phosphatase-coupled anti-rabbit secondary antibody, or peroxidase-coupled anti-HA (1:2,000) antibodies. Extracts were prepared from pSCR::33GFP:BDL or pSCR::33GFP:bdl seedlings and equal protein amounts were subjected to Western blotting and detection using mouse anti-GFP antibodies (1:1,000; Roche). For yeast twohybrid assays, serial deletions of BDL (1, full-length; 2, aa 1-156; 3, aa 1-143; 4, aa 1-130; 5, aa 1-116; see Figure 1C ) were PCR amplified and cloned as fusions to LexA in pEG202. Quantitative LacZ assays were performed on 12 independent colonies obtained after cotransformation of each deletion construct with pJG MP-C (Hamann et al., 2002; Weijers et al., 2005) .
Expression Analysis GUS activity assays and microscopy were performed as described . GFP fluorescence was analyzed in whole-mount roots or embryos using a Zeiss (Oberkochen, Germany) Axiophot epifluorescence microscope or Leica (Wetzlar, Germany) confocal laser scanning microscope. Immunofluorescence with anti-HA (1:600; Babco), rabbit anti-GFP (1:1,000; Molecular Probes), mouse anti-GFP (1:1,000; Molecular Probes), or anti-PIN1 (1:400; Friml et al., 2003) antibodies was performed as described (Lauber et al., 1997) .
Supplemental Data
Supplemental Data include two figures and are available at http:// www.developmentalcell.com/cgi/content/full/10/2/265/DC1/.
